Order Article Reprints

Caltavituro A, Buonaiuto R, Pietroluongo E, Morra R, Salomone F, De Placido P, Pagliuca M, Vaia A, Ottaviano M, Tortora M, et al. Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype. Biomedicines. 2023; 11(3):874. https://doi.org/10.3390/biomedicines11030874

Caltavituro, Aldo, Roberto Buonaiuto, Erica Pietroluongo, Rocco Morra, Fabio Salomone, Pietro De Placido, Martina Pagliuca, Angelo Vaia, Margaret Ottaviano, Marianna Tortora, and et al. 2023. "Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype" Biomedicines 11, no. 3: 874. https://doi.org/10.3390/biomedicines11030874

Caltavituro, A., Buonaiuto, R., Pietroluongo, E., Morra, R., Salomone, F., De Placido, P., Pagliuca, M., Vaia, A., Ottaviano, M., Tortora, M., De Placido, S., Palmieri, G., & Giuliano, M. (2023). Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype. Biomedicines, 11(3), 874. https://doi.org/10.3390/biomedicines11030874